Stay updated on Nitazoxanide for Acute Influenza: Clinical Trial
Sign up to get notified when there's something new on the Nitazoxanide for Acute Influenza: Clinical Trial page.

Latest updates to the Nitazoxanide for Acute Influenza: Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA banner announces an NIH-wide transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 while the study record page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now displays a 403 Forbidden error with a simple header and a Home button, replacing the previous detailed study record content. The former sections listing conditions, locations, and study details have been removed.SummaryDifference17%

- Check44 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a maintenance update to the page's version/documentation.SummaryDifference0.0%

Stay in the know with updates to Nitazoxanide for Acute Influenza: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nitazoxanide for Acute Influenza: Clinical Trial page.